DYN - Dyne Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DYN is currently covered by 12 analysts with an average price target of $38.66. This is a potential upside of $21.86 (130.12%) from yesterday's end of day stock price of $16.8.

Dyne Therapeutics 's activity chart (see below) currently has 86 price targets and 97 ratings on display. The stock rating distribution of DYN is 77.78% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.1% with an average time for these price targets to be met of 205.4 days.

Highest price target for DYN is $60, Lowest price target is $16, average price target is $38.45.

Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 20-Jan-2026. First documented stock forecast 12-Oct-2020.

Split History since 2000:

5/25/10 1 for 5

8/22/00 2 for 1

2/1/00 69 for 100

Currently out of the existing stock ratings of DYN, 28 are a BUY (77.78%), 8 are a HOLD (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 24-Oct-2024

$16

$-0.8 (-4.76%)

$17

20 days ago
(20-Jan-2026)

9/11 (81.82%)

$-0.58 (-3.50%)

105

Buy Since 12-Oct-2020

$39

$22.2 (132.14%)

$36

1 months 29 days ago
(11-Dec-2025)

5/9 (55.56%)

$19.58 (100.82%)

418

Buy Since 10-Dec-2025

$40

$23.2 (138.10%)

$11

1 months 30 days ago
(10-Dec-2025)

1/5 (20%)

$20.31 (103.15%)

19

Buy Since 20-Feb-2024

$60

$43.2 (257.14%)

$38

2 months 1 days ago
(08-Dec-2025)

2/11 (18.18%)

$37.8 (170.27%)

104

Buy Since 26-Jun-2025

$35

$18.2 (108.33%)

$30

2 months 1 days ago
(08-Dec-2025)

0/2 (0%)

$12.8 (57.66%)

Show more analysts

Please expand the browser size to see the chart

What is DYN (Dyne Therapeutics ) average time for price targets to be met?

On average it took 205.4 days on average for the stock forecasts to be realized with a an average price target met ratio 43.1

Which analyst has the current highest performing score on DYN (Dyne Therapeutics ) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on DYN (Dyne Therapeutics )?

Francois Brisebois works at LIFESCI and has 3 price targets and 2 ratings on DYN

Which analyst is the currently most bullish on DYN (Dyne Therapeutics )?

Andrew Fein with highest potential upside - $43.2

Which analyst is the currently most reserved on DYN (Dyne Therapeutics )?

Tessa Romero with lowest potential downside - -$0.8

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?